{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-125696","form_type":"8-K","ticker":"PBH","cik":"0001295947","company_name":"Prestige Consumer Healthcare Inc.","filed_at":"2023-12-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.554095+00:00","generated_at":"2026-06-07T13:21:27.858703+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Prestige Consumer Healthcare amends ABL facility: $41.5M commitment increase, maturity extended to 2028","bullets":["Revolving credit commitments increased by $41.5M (exhibit shows $41.5M, not $25M cited in filing summary).","Maturity extended to five years from Dec 8, 2023 (Dec 8, 2028), subject to springing maturity.","Deutsche Bank NY Branch exited as lender; a new lender joined with assignments and reallocations.","Amendment provides increased flexibility on restricted payments, debt incurrence, and borrowing base.","Borrower paid amendment fees: 0.10% of outstanding commitments plus 0.15% of new money commitments."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-125696","json":"https://secwatch.observer/filing/0001104659-23-125696.json","markdown":"https://secwatch.observer/filing/0001104659-23-125696.md","text":"https://secwatch.observer/filing/0001104659-23-125696.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1295947/000110465923125696/0001104659-23-125696-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1295947/000110465923125696/tm2332799d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T13:21:27.858703+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"87df631e4fab1a5cd7c243fd82b649d365ffb8ad","claim":"Prestige Consumer Healthcare Inc. amended revolving credit of $25 million increase in the aggregate revolving commitments with Citibank, N.A., as administrative agent, L/C issuer and swing line lender maturing five years from the effective date of the Amendment.","evidence_excerpt":"The Amendment provides for (i) a $25 million increase in the aggregate revolving commitments of all lenders under the Credit Agreement, (ii) an extension of the maturity date of the Credit Agreement to the date that is five years from the effective date of the Amendment","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1295947/000110465923125696/0001104659-23-125696-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"revolving credit"},{"label":"Principal","value":"$25 million increase in the aggregate revolving commitments"},{"label":"Counterparty","value":"Citibank, N.A., as administrative agent, L/C issuer and swing line lender"},{"label":"Maturity","value":"five years from the effective date of the Amendment"},{"label":"Event","value":"amendment"}],"fact_type":"debt_financing"},{"claim_id":"9c6d44ec78e57f0cff9beddd7bb88a31757fc273","claim":"Prestige Consumer Healthcare Inc. amended Amendment No. 9 with Citibank, N.A., as administrative agent, L/C issuer and swing line lender (effective 2023-12-08).","evidence_excerpt":"On December 8, 2023, Prestige Consumer Healthcare Inc. (the “ Company ”) and its wholly owned subsidiary, Prestige Brands, Inc. (the “ Borrower ”) entered into Amendment No. 9 (the “ Amendment ”) to the ABL Credit Agreement","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1295947/000110465923125696/0001104659-23-125696-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Citibank, N.A., as administrative agent, L/C issuer and swing line lender"},{"label":"Effective","value":"2023-12-08"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}